Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • @ghostBones
    link
    English
    31 year ago

    I have often said that the most intolerable offense in America is obstruction of profit, based on the sheer volume of litigation that fits that description.